Possessing a robust background in technology and healthcare investments, the fund manager has successfully executed over 30 deals across North America and Europe. With a thematic investment strategy, they prioritize data-driven insights to identify high-growth opportunities. Their operator-first approach has led to several notable exits, including a significant acquisition in the biotech sector, showcasing their ability to generate substantial returns. This manager’s expertise reflects a commitment to fostering innovation while maintaining a sharp focus on long-term value creation.